liensinine has been researched along with Innate Inflammatory Response in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, M; Dong, J; Dong, Z; Fan, H; Pan, E; Qiang, J; Shi, J; Tan, X; Wang, H; Wang, Y; Xu, B; Yang, Y; Zhang, X | 1 |
| Chen, H; Dong, J; Dong, Z; Fan, H; Li, X; Liu, F; Wang, T; Yang, H; Zhang, W; Zhang, X | 1 |
| Dai, D; Dong, J; Fan, H; Sun, Y; Wang, G; Yang, Q; Zhang, L; Zhang, W; Zhao, P | 1 |
| Chen, H; Dong, J; He, N; Shen, J; Tan, X; Xu, Z; Zhang, W; Zhang, X | 1 |
4 other study(ies) available for liensinine and Innate Inflammatory Response
| Article | Year |
|---|---|
Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model.
Topics: Animals; Apoptosis; Inflammation; Lipopolysaccharides; Mice; Oxidative Stress; Sepsis; Spleen | 2023 |
Liensinine alleviates septic heart injury by targeting inflammation, oxidative stress, apoptosis, and autophagy.
Topics: Apoptosis; Autophagy; Heart Injuries; Humans; Inflammation; Oxidative Stress | 2023 |
Liensinine, a alkaloid from lotus plumule, mitigates lipopolysaccharide-induced sepsis-associated encephalopathy through modulation of nuclear factor erythroid 2-related factor-mediated inflammatory biomarkers and mitochondria apoptosis.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Inflammation; Lipopolysaccharides; Lotus; Mice; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Sepsis-Associated Encephalopathy | 2023 |
Liensinine pretreatment reduces inflammation, oxidative stress, apoptosis, and autophagy to alleviate sepsis acute kidney injury.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Autophagy; Inflammation; Lipopolysaccharides; Mice; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Sepsis | 2023 |